Methods for controlling progression of hyperparathyroidism with calcifediol and compositions for use therein
JP2025031720A5Pending Publication Date: 2025-06-24AIRGEN PHARMA LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- JP2024204631
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-02-06
- Filing Date
- 2024-11-25
- Publication Date
- 2025-06-24
Smart Images

Figure 00000044_0000 
Figure 00000044_0001 
Figure 00000045_0000
Abstract
To provide methods and compositions for regulating hyperparathyroidism.SOLUTION: One aspect of the disclosure is a method for preventing, halting or reversing the SHPT progression in a subject, e.g., a human adult, defined as an increase in iPTH by >10% from the pretreatment baseline, the method comprising effective administration of 25-hydroxyvitamin D to increase and maintain serum total 25-hydroxyvitamin D in the patient to a concentration greater than 50 ng / mL, optionally at least 50.8 ng / mL, optionally at least 51 ng / mL or at least 60 ng / mL, and thereby preventing, halting, or reversing SHPT progression in the patient.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art